Nanoparticles
For Application in Theranostics

Next Generation Human Serum Albumin Nanoparticles
for the Application in Theranostics


Stams Diagnostics has solved the challenges of creating nanoparticles for specific targeting and cell uptake.
  • Defined uniform size.
  • Stochiometric attachment of targeting groups.
  • Defined attachment of imaging groups or other effector molecules.
  • Rapid, specific and stable target binding within a few minutes.
  • High in vivo stability.
  • Resistant to conditions in the gastrointestinal tract.
  • Non-aggregating.
  • Non-toxic.
  • Cost-effective production.
  • Straightforward upscalability.
  • Fridge storage life exceeds two years.
  • Compatible with all conventional fluorochromes.
  • Ready for polychromatic imaging of different targets.
Our Team

Prof. Dr. Paul Debbage

Managing Director
Principle Investigator

Dr. Gudrun Thurner

Senior Investigator
THE LAST TEN MICROMETERS
Targeting in (Nano)medicine"

Wilhelm Exner Lecture at the Gala 2019, October 16th
by Prof. Dr. Paul Debbage
Principle investigator and founder of Stams Diagnostics GmbH, Paul Debbage, describes the challeges of targeting by nano particles and suggests a solution.
View more

 Financial support provided by the AplusB scale-up programme